Byravee Iyer
Jan 22, 2013

Ego Pharmaceutical retains Ogilvy Group Melbourne as AOR

MELBOURNE - Australian skin care company Ego Pharmaceuticals has retained incumbent agency Ogilvy Group Melbourne as its agency-of-record following a four-way pitch.

Taylor: aims to attract
Taylor: aims to attract "a range of new customers interested in the best products for themselves and their families"

The account will be lead by the company’s brand activation consultancy Ogilvy Action. The retail marketing agency will work with a range of experts hand-picked from other Ogilvy Group Melbourne agencies including BADJAR Ogilvy, production company One20, DT and STW Group’s Ikon to ensure both in-store and out-of-store digital execution.

“Ego and QV {Queen Victoria Hospital] have an incredible heritage and story to tell, one that we believe will engage consumers, and grow awareness among the broader market,” explained OgilvyAction CEO, Sean Taylor. Taylor said the agency’s first project would primarily target expecting and new mothers, interested in the best products for themselves and their children. “Many consumers may not be aware that QV actually stands for Queen Victoria hospital, for which the product was originally developed. We will work to deliver this message while attracting a range of new customers interested in the best products for themselves and their families.”

 

 

Source:
Campaign Asia

Related Articles

Just Published

5 hours ago

Spotify’s global ad revenue expected to reach $2.1 ...

Company plans to continue investment into video advertising and driving revenue through gen AI tools as it expects to grow by 13% in 2026.

5 hours ago

Publicis Groupe buys Mars United Commerce for ...

The acquisition follows Publicis Groupe’s purchase of Influential this summer.

14 hours ago

S4 Capital reports 13.5% revenue fall and increased ...

Its AI positioning has led to new business from blue chips, the group said.

15 hours ago

Breaking down the implications of Google’s ad tech ...

What both sides need to argue to win — and the potential ramifications to follow.